Continuing Medical Education: Comply with the Latest Changes to Funding Rules

Purchase Option Price

Product Description:

WEBCAST ON CD

Sponsored by ePharmaceuticals' CME Training Course

presented on November 19, 2008

Industry support of continuing medical education (CME) is not only acceptable, it can be appropriate. However, it also has the potential to introduce commercial bias that threatens the integrity of the CME event or publication. To reduce the risk of bias, PhRMA, the OIG, the FDA, and the American Council for Continuing Medical Education (ACCME) have created guidance applicable to industry support of CME.

The rules and guidance surrounding industry support for CME are constantly evolving. The revised PhRMA Code on Interactions with Healthcare Professionals reinforces the OIG's 2003 recommendation that companies separate their grant-making department from sales and marketing. In addition, some states are now requiring compliance with the PhRMA Code and OIG guidance. In the wake of Congressional criticism, some companies are disclosing their grants, while academic institutions are revising their criteria for accepting industry support for CME.

Reduce your risk of non-compliance

Remain current with the changing environment surrounding industry support for CME and learn how to maintain medical education in a compliant manner. Listen to ePharmaceuticals' Webcast: Continuing Medical Education: Comply with the Latest Changes to Funding Rules. Healthcare compliance attorney Kathleen Peterson, Esq. (Epstein Becker & Green) and CME specialist Betsy S. Woodall, PharmD, MBA, BCPS (Wyeth Pharmaceuticals) provide listeners with an industry perspective on CME funding and analysis of how recent changes to the PhRMA Code and state laws will affect how companies offer and provide grants. In addition, the speakers offer tips to help participants implement changes within their organization.

Related Products